+Compare
CHEK
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$0.34
Change
-$0.00 (-0.00%)
Capitalization
39.58M

CHEK Check-Cap Ltd Forecast, Technical & Fundamental Analysis

a developer of gastrointestinal imaging devices
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

CHEK in +6.75% Uptrend, rising for three consecutive days on August 05, 2022

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CHEK advanced for three days, in 175 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 74 cases where CHEK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CHEK just turned positive on August 05, 2022. Looking at past instances where CHEK's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

CHEK moved above its 50-day moving average on August 05, 2022 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 60 cases where CHEK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 28, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on CHEK as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHEK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CHEK broke above its upper Bollinger Band on July 21, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.734) is normal, around the industry mean (17.233). P/E Ratio (0.000) is within average values for comparable stocks, (93.645). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.735). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (92.257).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CHEK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHEK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI

View a ticker or compare two or three

CHEK
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published Earnings

CHEK is expected to report earnings to fall 16.67% to -5 cents per share on August 11

Check-Cap Ltd CHEK Stock Earnings Reports
Q2'22
Est.
$-0.05
Q1'22
Missed
by $0.01
Q4'21
Missed
by $0.05
Q3'21
Beat
by $0.01
Q2'21
Missed
by $0.01
The last earnings report on June 01 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 217.17K shares outstanding, the current market capitalization sits at 39.58M.
AI
A.I. Advisor
published General Information

General Information

a developer of gastrointestinal imaging devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
29 Abba Hushi Avenue
Phone
+972 546706451
Employees
81
Web
https://www.check-cap.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACW27.900.37
+1.34%
PacWest Bancorp
HSKA87.550.15
+0.17%
Heska Corp
BCOV6.42N/A
N/A
Brightcove
ZBH113.26-0.09
-0.08%
Zimmer Biomet Holdings
NBEV0.26-0.01
-3.23%
NewAge

CHEK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHEK has been loosely correlated with ASXC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CHEK jumps, then ASXC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEK
1D Price
Change %
CHEK100%
+1.52%
ASXC - CHEK
39%
Loosely correlated
+2.97%
BNGO - CHEK
39%
Loosely correlated
+2.55%
BFLY - CHEK
34%
Loosely correlated
+11.15%
QTRX - CHEK
34%
Loosely correlated
+1.63%
PSNL - CHEK
32%
Poorly correlated
+10.22%
More